Reconsidering the Roles of the Mineralocorticoid Receptor
Open Access
- 1 February 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 53 (2) , 286-290
- https://doi.org/10.1161/hypertensionaha.108.119966
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- TRANSLATIONAL RESEARCH GOES BOTH WAYS: LESSONS FROM CLINICAL STUDIESClinical and Experimental Pharmacology and Physiology, 2008
- The Evolution of Mineralocorticoid ReceptorsMolecular Endocrinology, 2006
- Evidence for Abnormal Left Ventricular Structure and Function in Normotensive Individuals with Familial Hyperaldosteronism Type IJournal of Clinical Endocrinology & Metabolism, 2005
- Distinguishing the Antihypertensive and Electrolyte Effects of EplerenoneJournal of Clinical Endocrinology & Metabolism, 2004
- Effects of Eplerenone, Enalapril, and Eplerenone/Enalapril in Patients With Essential Hypertension and Left Ventricular HypertrophyCirculation, 2003
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- The Pathophysiology of Aldosterone in the Cardiovascular SystemAnnals of the New York Academy of Sciences, 2002
- Heart rate dependency of pulse pressure amplification and arterial stiffnessAmerican Journal of Hypertension, 2002
- Activating Mineralocorticoid Receptor Mutation in Hypertension Exacerbated by PregnancyScience, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999